Superficial Cervical Plexus Block for IJCL Pain Management

NCT05252832 | Completed

• 1 other identifier: 21003
• Study Type: interventional
• Target: 14
• Locations: 1 country
• Sites: 1

Brief Summary

This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.

Conditions

Superficial Cervical Plexus Block; Pain

Keywords

Superficial Cervical Plexus Block; Pain Management

Outcome Measures

Primary Outcomes (1)

• Visual Analog Scale Rating

  The average Visual Analog Scale (VAS) rating in patients who receive the SCPB during internal jugular venous cannulation versus the average VAS in patients receiving local infiltration. The scale is from 0-10, with 0 meaning no pain and 10 meaning the most pain I have ever experienced.

  30 minutes post central line placement

Secondary Outcomes (1)

• Complications

  Duration of emergency department and inpatient encounter, typically no more than 7 days.

Study Arms (2)

Local Infitrate

ACTIVE COMPARATOR

Procedure: Local Infiltrate

SCPB

EXPERIMENTAL

Procedure: Superficial Cervical Plexus Block

Interventions

Superficial Cervical Plexus Block PROCEDURE

Location of injection for block.

SCPB

Local Infiltrate PROCEDURE

Local infiltration location.

Local Infitrate

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Patients who are 18 years and older, and;
• Present to the Akron General Emergency Department (Main) between March 1, 2021 and December 1, 2022, and;
• Require IJVC as a part of their clinical care.

You may not qualify if:

• Patients who are intubated; or
• Patients who undergo CPR; or
• Patients who have an allergy to lidocaine or bupivacaine; or
• Patients who have a contraindication to receiving a superficial cervical plexus block such as cellulitis over Erb's point or the internal jugular vein, abnormal anatomy, or prior surgery to the area.

Sponsors & Collaborators

• Cleveland Clinic Akron General: lead

Study Sites (1)

Cleveland Clinic Akron General

Akron, Ohio, 44307, United States

Location

MeSH Terms

Conditions

Pain; Agnosia

Condition Hierarchy (Ancestors)

Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Perceptual Disorders; Neurobehavioral Manifestations; Nervous System Diseases

Study Officials

• Robert Stenberg, MD

  Cleveland Clinic Akron General

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Masking Details: Participants will be masked to the anesthesia route selected until after they report their pain scale report. Care provider cannot be blinded in order to complete.
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator, Ultrasound Director, Assistant Professor, Emergency Medicine Physician

Model Details: Participant blinded block randomization of the control local infitrate (Arm 1) and the experimental SCPB (Arm 2).

Study Record Dates

• First Submitted: December 7, 2021
• First Posted: February 23, 2022
• Study Start: January 15, 2022
• Primary Completion: January 20, 2024
• Study Completion: December 31, 2024
• Last Updated: May 4, 2025

Record last verified: 2025-04

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)